The fanconi anaemia genome stability and tumour suppressor network

Mutagenesis

Volumn 17, Issue 6, 2002, Pages 529-538

  Bogliolo, M ^a   Cabre O ^a   Callen E ^a   Castillo, V ^a   Creus, A ^a   Marcos, R ^a   Surralles J ^a  

^a UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ATM PROTEIN; BRCA1 PROTEIN; BRCA2 PROTEIN; DNA; PHOSPHOPROTEIN; REACTIVE OXYGEN METABOLITE; TUMOR SUPPRESSOR PROTEIN; CELL CYCLE PROTEIN; DNA BINDING PROTEIN; FANCD2 PROTEIN, HUMAN; FANCONI ANEMIA GROUP D2 PROTEIN; NUCLEAR PROTEIN; PROTEIN SERINE THREONINE KINASE;

APOPTOSIS; ATAXIA TELANGIECTASIA; AUTOSOMAL RECESSIVE DISORDER; CANCER PREVENTION; CANCER SUSCEPTIBILITY; CARCINOGENICITY; CELL CYCLE; CELL NUCLEUS; CYTOPLASM; DNA CROSS LINKING; FANCONI ANEMIA; GENE ACTIVATION; GENE FUNCTION; GENE MUTATION; GENETIC STABILITY; HUMAN; HUMAN CELL; IONIZING RADIATION; MOLECULAR BIOLOGY; PANCYTOPENIA; PRIORITY JOURNAL; PROTEIN INTERACTION; PROTEIN PHOSPHORYLATION; REVIEW; STRESS; TELOMERE; XENOBIOTIC METABOLISM; BIOLOGICAL MODEL; CHROMATIN; DNA REPAIR; FEMALE; GENETIC TRANSCRIPTION; GENETICS; MALE; METABOLISM; MUTATION; OXIDATIVE STRESS; PATHOLOGY; TUMOR SUPPRESSOR GENE;

ATAXIA; ATAXIA TELANGIECTASIA; PYRONIA TITHONUS;

APOPTOSIS; CELL CYCLE; CELL CYCLE PROTEINS; CELL NUCLEUS; CHROMATIN; DNA REPAIR; DNA-BINDING PROTEINS; FANCONI ANEMIA; FANCONI ANEMIA COMPLEMENTATION GROUP D2 PROTEIN; FEMALE; GENES, BRCA1; GENES, BRCA2; GENES, TUMOR SUPPRESSOR; HUMANS; MALE; MODELS, BIOLOGICAL; MUTATION; NUCLEAR PROTEINS; OXIDATIVE STRESS; PROTEIN-SERINE-THREONINE KINASES; TELOMERE; TRANSCRIPTION, GENETIC; TUMOR SUPPRESSOR PROTEINS;

EID: 0036856479     PISSN: 02678357     EISSN: None     Source Type: Journal    
DOI: 10.1093/mutage/17.6.529     Document Type: Review

References (141)

1. Abraham, R.T. (2001) Cell cycle checkpoint signaling through the ATM and ATR kinases. Genes Dev., 15, 2177-2196.
2. Adler, V., Yin, Z., Tew, K.D. and Ronai, Z. (1999) Role of redox potential and reactive oxygen species in stress signaling. Oncogene, 18, 6104-6111.
3. Aguilera, A. (2002) The connection between transcription and genomic instability. EMBO J., 21, 195-201.
4. Alter, B.P. (1996) Fanconi's anemia and malignancies. Am. J. Hematol., 53, 99-110.
5. Auerbach, A.D., Buchwald, M. and Joenje, H. (1997) Fanconi anaemia. In Vogelstein, B. and Kinzler, K.W. (eds), The Genetic Basis of Human Cancer. McGraw-Hill, New York, NY.
6. Balin, A.K., Goodman, D.B.P., Rasmussen, H. and Cristofalo, V.J. (1978) Oxygen-sensitive stages of cell cycle of human diploid cells. J. Cell. Biol., 78, 390.
7. Ball, S.E., Gibson, F.M., Rizzo, S., Tooze, J.A., Marsh, J.C. and Gordon-Smith, E.C. (1998) Progressive telomere shortening in aplastic anemia. Blood, 15, 3582-3592.
8. Belcourt, M.F., Hodnick, W.F., Rockwell, S. and Sartorelli, A.C. (1996) Differential toxicity of mitomycin C and porfiromycin to aerobic and hypoxic Chinese hamster ovary cells overexpressing human NADPH:cytochrome c (P-450) reductase. Proc. Natl Acad. Sci. USA, 93, 456-460.
9. Blasco, M.A., Lee, H.W., Hande, M.P., Samper, E., Lansdorp, P.M., DePinho, R.A. and Greider, C.W. (1997) Telomerase shortening and tumor formation by mouse cells lacking telomerase RNA. Cell, 91, 25-34.
10. Bochar, D.A., Wang, L., Beniya, H., Kinev, A., Xue, Y., Lane, W.S., Wang, W., Kashanchi, F. and Shiekhattar, R. (2000) BRCA1 is associated with a human SWI/SNF-related complex: linking chromatin remodeling to breast cancer. Cell, 102, 257-265.
11. Bogliolo, M., Taylor, R.M., Caldecott, K.W. and Frosina, G. (2000) Reduced ligation during DNA base excision repair supported by BRCA2 mutant cells. Oncogene, 19, 5781-5787.
12. Bogliolo, M., Borghini, S., Abbondandolo, A. and Degan, P. (2002) Alternative metabolic pathways for energy supply and resistance to apoptosis in Fanconi anaemia. Mutagenesis, 17, 25-30.
13. Boultwood, J., Fidler, C., Kusec, R., Rack, K., Elliott, P.J., Atoyebi, O., Chapman, R., Oscier, D.G. and Wainscoat, J.S. (1997) Telomere length in myelodysplastic syndromes. Am. J. Hematol., 56, 266-271.
14. Brummendorf, T.H., Maciejewski, J.P., Mak, J., Young, N.S. and Lansdorp, P.M. (2001) Telomere length in leukocyte subpopulations of patients with aplastic anemia. Blood, 97, 895-900.
15. Callén, E., Samper, E., Ramírez, M.J., Creus, A., Marcos, R., Ortega, J.J., Olivé, T., Badell, I., Blasco, M.A. and Surrallés, J. (2002a) Breaks at telomeres and TRF2-independent end-fusions in Fanconi anemia. Hum. Mol. Genet., 11, 439-444.
16. Callén, E., Ramírez, M.J., Creus, A., Marcos, R., Ortega, J.J., Olivé, T., Badell, I. and Surrallés, J. (2002b) Relationship between chromosome fragility, aneuploidy and severity of the haematological disease in Fanconi anaemia. Mutat. Res., 504, 78-87.
17. Callén, E., Ramírez, M.J., Creus, A., Marcos, R., Frias, S., Molina, B., Badell, I., Olivé, T., Ortega, J.J. and Surrallés, J. (2002c) The clastogenic response of the 1q12 heterochromatic region to DNA cross-linking agents is independent of the Fanconi anemia pathway. Carcinogenesis, 23, 1267-1274.
18. Casado, J.A., Segovia, J.C., Lamana, M., Lozano, M.L., Callén, E., Surrallés, J., Lobitz, S., Hanenberg, H. and Bueren, J.A. (2001) Subtyping of Fanconi anemia patients from Spain using the retroviral complementation assay. Fanconi Anemia Research Fund Symposium, Abstract Book. Fanconi Anemia Research Fund, Portland, OR.
19. Centurion, S.A., Kuo, H.R. and Lambert, W.C. (2000) Damage-resistant DNA synthesis in Fanconi anaemia cells treated with a DNA cross-linking agent. Exp. Cell. Res., 260, 216-221.
20. Clarke, A.A., Philpott, N.J., Gordon-Smith, E.C. and Rutherford, T.R. (1997) The sensitivity of Fanconi anaemia group C cells to apoptosis induced by mitomycin C is due to oxygen radical generation, not DNA cross-linking. Br. J. Haematol., 96, 240-247.
21. Connor, F., Bertwistle, D., Mee, P.J., Ross, G.M., Swift, S., Grigorieva, E., Tybulewicz, V.L. and Ashworth, A. (1997) Tumorigenesis and a DNA repair defect in mice with a truncating Brca2 mutation. Nature Genet., 4, 423-430.
22. Cumming, R.C., Liu, J.M., Youssoufian, H. and Buchwald, M. (1996) Suppression of apoptosis in hematopoietic factor-dependent progenitor cell lines by expression of the FAC gene. Blood, 88, 4558-4567.
23. Cumming, R.C., Lightfoot, J., Beard, K., Youssoufian, H., O'Brien, P.J. and Buchwald, M. (2001) Fanconi anaemia group C protein prevents apoptosis in hematopoietic cells through redox regulation of GSTP1. Nature Med., 7, 814-820.
24. D'Andrea, A.D. (1996) Fanconi anaemia forges a novel pathway. Nature Genet., 14, 240-242.
25. Dai, M.S., Chevallier, N., Stone, S., Heinrich, M.C., McConnell, M., Reuter, T., Broxmeyer, H.E., Licht, J.D., Lu, L. and Hoatlin, M.E. (2002) The effects of the Fanconi anemia zinc finger (FAZF) on cell cycle, apoptosis and proliferation are differentiation-stage specific, J. Biol. Chem., 277, 26327-26334.
26. de Winter, J.P., Waisfisz, Q., Rooimans, M.A. et al. (1998) The Fanconi anemia group G gene FANCG is identical with XRCC9. Nature Genet., 20, 281-283.
27. de Winter, J.P., Leveille, F., van Berkel, C.G. et al. (2000a) Isolation of a cDNA representing the Fanconi anemia complementation group E gene. Am. J. Hum. Genet., 67, 1306-1308.
28. de Winter, J.P., Rooimans, M.A., van Der Weel, L. et al. (2000b) The Fanconi anemia gene FANCF encodes a novel protein with homology to ROM. Nature Genet., 24, 15-16.
29. Degan, P., Bonassi, S., De Caterina, M., Korkina, L.G., Pinto, L., Scopacasa, F., Zatterale, A., Calzone, R. and Pagano, G. (1995) In vivo accumulation of 8-hydroxy-2′-deoxyguanosine in DNA correlates with release of reactive oxygen species in Fanconi's anaemia families. Carcinogenesis, 16, 735-741.
30. Dronkert, M.L. and Kanaar, R. (2001) Repair of DNA interstrand cross-links. Mutat. Res., 486, 217-247.
31. Dutrillaux, B., Aurias, A., Dutrillaux, A.M., Buriot, D. and Prieur, M. (1982) The cell cycle of lymphocytes in Fanconi anaemia. Hum. Genet., 62, 327-332.
32. Elledge, S.J. (1996) Cell cycle checkpoints: preventing an identity crisis. Science, 274, 1664-1672.
33. Escarceller, M., Rousset, S., Moustacchi, E. and Papadopoulo, D. (1997) The fidelity of double strand breaks processing is impaired in complementation groups B and D of Fanconi anemia, a genetic instability syndrome. Somat. Cell. Mol. Genet., 23, 401-411.
34. Escarceller, M., Buchwald, M., Singleton, B.K., Jeggo, P.A., Jackson, S.P., Moustacchi, E. and Papadopoulo, D. (1998) Fanconi anemia C gene product plays a role in the fidelity of blunt DNA end-joining. J. Mol. Biol., 279, 375-385.
35. Fagerlie, S.R., Diaz, J., Christianson, T.A., McCartan, K., Keeble, W., Faulkner, G.R. and Bagby, G.C. (2001) Functional correction of FA-C cells with FANCC suppresses the expression of interferon gamma-inducible genes. Blood, 97, 3017-3024.
36. Fanconi Anaemia/Breast Cancer Consortium (1996) Positional cloning of the Fanconi anemia group A gene. Nature Genet., 14, 324-328.
37. Futaki, M. and Liu, J.M. (2001) Chromosomal breakage syndromes and the BRCA1 genome surveillance complex. Trends Mol. Med., 7, 560-565.
38. Futaki, M., Watanabe, S., Kajigaya, S. and Liu, J.M. (2001) Fanconi anemia protein, FANCG, is a phosphoprotein and is upregulated with FANCA after TNF-alpha treatment. Biochem. Biophys. Res. Commun., 281, 347-351.
39. Futaki, M., Igarashi, T., Watanabe, S., Kajigaya, S., Tatsuguchi, A., Wang, J. and Liu, J.M. (2002) The FANCG Fanconi anemia protein interacts with CYP2E1: possible role in protection against oxidative DNA damage. Carcinogenesis, 23, 67-72.
40. Garcia-Higuera, I., Taniguchi, T., Ganesan, S., Meyn, M.S., Timmers, C., Hejna, J., Grompe, M. and D'Andrea, A.D. (2001) Interaction of the Fanconi anemia proteins and BRCA1 in a common pathway. Mol. Cell, 7, 249-262.
41. Grompe, M. and D'Andrea, A. (2001) Fanconi anemia and DNA repair. Hum. Mol. Genet., 10, 2253-2259.
42. Gush, K.A., Fu, K.L., Grompe, M. and Walsh, C.E. (2000) Phenotypic correction of Fanconi anemia group C knockout mice. Blood, 95, 700-704.
43. -/- mice and patients with ataxia-telangiectasia. Hum. Mol. Genet., 10, 519-528.
44. -/- mice. Blood, 91, 4092-4098.
45. Hanenberg, H., Batish, S.D., Pollok, K.E. et al. (2002) Phenotypic correction of primary Fanconi anemia T cells with retroviral vectors as a diagnostic tool. Exp. Hematol., 30, 410-420.
46. Hanson, H., Mathew, C.G., Docherty, Z. and Mackie Ogilvie, C. (2001) Telomere shortening in Fanconi anaemia demonstrated by a direct FISH approach. Cytogenet. Cell Genet., 93, 203-206
47. Hartwell, L.H. and Kastan, M.B. (1994) Cell cycle control and cancer. Science, 266, 1821-1828.
48. Herrera, E., Samper, E., Martín-Caballero, J., Flores, J.M., Lee, H.W. and Blasco, M.A. (1999) Disease states associated with telomerase deficiency appear earlier in mice with short telomeres. EMBO J., 18, 2950-2960
49. Hoatlin, M.E., Christianson, T.A., Keeble, W.W., Hammond, A.T., Zhi, Y., Heinrich, M.C., Tower, P.A. and Bagby, G.C. (1998) The Fanconi anaemia group C gene product is located in both the nucleus and cytoplasm of human cells. Blood, 91, 1418-1425.
50. Hoatlin, M.E., Zhi, Y., Ball, H. et al.. (1999) A novel BTB/POZ transcriptional repressor protein interacts with the Fanconi anemia group C protein and PLZF. Blood, 94, 3737-3747.
51. Hoehn, H., Kubbies, M., Schindler, D., Poot, M. and Rabinovitch, P.S. (1989) BrdU-Hoechst flow cytometry links the cell kinetic defect of Fanconi anaemia to oxygen hypersensitivity. In Schoeder-Kurth, T.M., Auerbach, A.D. and Obe, G. (eds), Fanconi Anaemia: Clinical, Cytogenetic and Experimental Aspects. Springer-Verlag, Berlin, Germany, pp. 174-182.
52. Hoeijmakers, J.H.J. (2001) Genome maintenance mechanisms for preventing cancer. Nature, 411, 366-374.
53. Hoshino, T., Wang, J., Devetten, M.P., Iwata, N., Kajigaya, S., Wise, R.J., Liu, J.M. and Youssoufian, H. (1998) Molecular chaperone GRP94 binds to the Fanconi anaemia group C protein and regulates its intracellular expression. Blood, 91, 4379-4386.
54. Howlett, N.G., Taniguchi, T., Olson, S. et al. (2002) Biallelic inactivation of BRCA2 in Fanconi anemia. Science, 297, 606-609.
55. Joenje, H. and Arwert, F. (2001) Connecting Fanconi anemia to BRCA1 Nature Med., 7, 406-407.
56. Joenje, H. and Oostra, A.B. (1983) Effect of oxygen tension on chromosomal aberrations in Fanconi anaemia. Hum. Genet., 65, 6599-6601.
57. Joenje, H. and Patel, K.J. (2001) The emerging genetic and molecular basis of Fanconi anaemia. Nature Rev. Genet., 2, 446-457.
58. Joenje, H., Arwert, F., Eriksson, A.W., de Koning, H. and Oostra, A.B. (1981) Oxygen-dependence of chromosomal aberrations in Fanconi's anaemia. Nature, 290, 142-143.
59. Joenje, H., Oostra, A.B., Wijker, M. et al.. (1997) Evidence for at least eight Fanconi anemia genes. Am. J. Hum. Genet., 61, 940-944.
60. Kastan, M.B. and Lim, D.S. (2000) The many substrates and functions of ATM. Nature Rev. Mol. Cell. Biol., 1, 179-186.
61. Kontou, M., Adelfalk, C., Ramirez, M.H., Ruppitsch, W., Hirsch-Kauffmann, M. and Schweiger, M. (2002) Overexpressed thioredoxin compensates Fanconi anemia related chromosomal instability. Oncogene, 21, 2406-2412.
62. Korkina, L.G., Deeva, I.B., De Biase, A., Iaccarino, M., Oral, R., Warnau, M. and Pagano, G. (2000) Redox-dependent toxicity of diepoxybutane and mitomycin C in sea urchin embryogenesis. Carcinogenesis, 21, 213-220.
63. Kruyt, F.A.E., Dijkmans, L.M., Van der Berg, T.K. and Joenje, H. (1996) Fanconi anaemia genes act to suppress a cross-linker-inducible p53-independent apoptosis pathway in lymphoblast cell lines. Blood, 87, 938-948.
64. Kruyt, F.A., Hoshino, T., Liu, J.M., Joseph, P., Jaiswal, A.K. and Youssoufian, H. (1998) Abnormal microsomal detoxification implicated in Fanconi anaemia group C by interaction of the FAC protein with NADPH cytochrome P450 reductase. Blood, 92, 3050-3056.
65. Kubbies, M., Schindler, D., Hoehn, H., Schinzel, A. and Rabinovitch, P.S. (1985) Endogenous blockage and delay of the chromosome cycle despite normal recruitment and growth phase explain poor proliferation and frequent edomitosis in Fanconi anemia cells. Am. J. Hum. Genet., 37, 1022-1030.
66. Kupfer, G.M. and D'Andrea, A.D. (1996) The effect of the Fanconi anaemia polypeptide, FAC, upon p53 induction and G2 checkpoint regulation. Blood, 88, 1019-1025.
67. Kupfer, G.M., Yamashita, T., Naf, D., Suliman, A., Asano, S. and D'Andrea, A.D. (1997) The Fanconi anemia polypeptide, FAC, binds to the cyclin-dependent kinase, cdc2. Blood, 90, 1047-1054.
68. Lackinger, D., Ruppitsch, W., Ramirez, M.H., Hirsch-Kauffmann, M. and Schweiger, M. (1998) Involvement of the Fanconi anemia protein FA-C in repair processes of oxidative DNA damages. FEBS Lett., 440, 103-106.
69. Lansdorp, P.M. (2000) Repair of telomeric DNA prior to replicative senescence. Mech. Ageing Dev., 118, 23-34.
70. Le Page, F., Randrianarison, V., Marot, D., Cabannes, J., Perricaudet, M., Feunteun, J. and Sarasin, A. (2000) BRCA1 and BRCA2 are necessary for the transcription-coupled repair of the oxidative 8-oxoguanine lesion in human cells. Cancer Res., 60, 5548-5552.
71. Lee, H.W., Blasco, M.A., Gottlieb, G.J., Horner, J.W., Greider, C.W. and DePinho, R.A. (1998) Essential role of mouse telomerase in highly proliferative organs. Nature, 392, 569-574.
72. Leteurtre, F., Li., X., Guardiola, P., Le Roux, G., Sergère, J.C., Richard, P., Carosella, E.D. and Gluckman, E. (1999) Accelerated telomere shortening and telomerase activation in Fanconi's anaemia. Br. J. Hematol., 105, 883-893.
73. Liu, N., Lamerdin, J.E., Tucker, J.D., Zhou, Z.Q., Walter, C.A., Albala, J.S., Busch, D.B. and Thompson, L.H. (1997) The human XRCC9 gene corrects chromosomal instability and mutagen sensitivities in CHO UV40 cells. Proc. Natl Acad. Sci. USA, 94, 9232-9237.
74. Loft, S. and Poulsen, H.E. (1996) Cancer risk and oxidative DNA damage in man. J. Mol. Med., 74, 297-312.
75. Lo Ten Foe, J.R., Rooimans, M.A., Bosnoyan-Collins, L. et al. (1996) Expression cloning of a cDNA for the major Fanconi anaemia gene, FAA. Nature Genet., 14, 320-323.
76. Lo Ten Foe, J.R., Kwee, M.L., Rooimans, M.A. et al. (1997) Somatic mosaicism in Fanconi anemia: molecular basis and clinical significance. Eur. J. Hum. Genet., 5, 137-148.
77. Lundberg, R., Mavinakere, M. and Campbell, C. (2001) Deficient DNA end joining activity in extracts from Fancom anemia fibroblasts. J. Biol. Chem., 276, 9543-9549.
78. Marnett, L.J. (2000) Oxyradicals and DNA damage. Carcinogenesis, 21, 361-370.
79. Metcalfe, J.A., Parkhill, J., Campbell, L., Stacey, M., Biggs, P., Byrd, P.J. and Taylor, A.M. (1996) Accelerated telomere shortening in ataxia telangiectasia. Nature Genet., 13, 350-353.
80. Mian, I.S. and Moser, M.J. (1998) The Fanconi anaemia complementation group A protein contains a peroxidase domain. Mol. Genet. Metab., 63, 230-234.
81. Obin, M., Shang, F., Gong, X., Handelman, G., Blumberg, J. and Taylor, A. (1998) Redox regulation of ubiquitin-conjugating enzymes: mechanistic insights using the thiol-specific oxidant diamide. FASEB J., 12, 561-569.
82. Oikawa, S. and Kawanishi, S. (1999) Site-specific DNA damage at GGG sequence by oxidative stress may accelerate telomere shortening. FEBS Lett., 453, 365-368.
83. Otsuki, T., Furukawa, Y., Ikeda, K., Endo, H., Yamashita, T., Shinohara, A., Iwamatsu, A., Ozawa, K. and Liu, J.M. (2001) Fanconi anemia protein, FANCA, associates with BRG1, a component of the human SWI/SNF complex. Hum. Mol. Genet., 10, 2651-2660.
84. Pace, P., Johnson, M., Tan, W.M., Mosdale, G., Sng, C., Hoatlin, M., de Winter, J., Joenje, H., Gergely, F. and Patel, K. (2002) FANCE: the link between Fanconi anaemia complex assembly and activity. EMBO J., 21, 3414-3423.
85. Pagano, G. (2000) Mitomycin C and diepoxybutane action mechanisms and FANCC protein functions: further insights into the role for oxidative stress in Fanconi's anaemia phenotype. Carcinogenesis, 21, 1067-1068.
86. Pang, Q., Fagerlie, S., Christianson, T.A., Keeble, W., Faulkner, G., Diaz, J., Rathbun, R.K. and Bagby, G.C. (2000) The Fanconi anaemia protein FANCC binds to and facilitates the activation of STAT1 by IFN-g and hematopoietic growth factors. Mol. Cell. Biol., 20, 4724-4735.
87. Pang, Q., Christianson, T.A., Keeble, W., Diaz, J., Faulkner, G.R., Reifsteck, C., Olson, S. and Bagby, G.C. (2001a) The Fanconi anemia complementation group C gene product: structural evidence of multifunctionality. Blood, 98, 1392-1401.
88. Pang, Q., Keeble, W., Christianson, T.A., Faulkner, G.R. and Bagby, G.C. (2001b) FANCC interacts with Hsp70 to protect hematopoietic cells from IFN-γ/ TNF-α-mediated cytotoxicity. EMBO J., 20, 4478-4489.
89. Pang, Q., Keeble, W., Diaz, J., Christianson, T.A., Fagerlie, S., Rathbun, K., Faulkner, G.R., O'Dwyer, M. and Bagby, G.C. (2001c) Role of double-stranded RNA-dependent protein kinase in mediating hypersensitivity of Fanconi anemia complementation group C cells to interferon gamma, tumor necrosis factor-alpha and double-stranded RNA. Blood, 97, 1644-1652.
90. Patel, K.J., Yu, V.P., Lee, H., Corcoran, A., Thistlethwaite, F.C., Evans, M.J., Colledge, W.H., Friedman, L.S., Ponder, B.A. and Venkitaraman, A.R. (1998) Involvement of Brca2 in DNA repair. Mol. Cell, 1, 347-357.
91. Pincheira, J., Bravo, M. and Lopez-Saez, J.F. (1988) Fanconi's anemia lymphocytes: effect of caffeine, adenosine and niacinamide during G2 prophase. Mutat. Res., 199, 159-165.
92. Pincheira, J., Bravo, M., Santos, M.J., de la Torre, C. and Lopez-Saez, J.F. (2001) Fanconi anemia lymphocytes: effect of DL-alpha-tocopherol (vitamin E) on chromatid breaks and on G2 repair efficiency. Mutat. Res., 461, 265-271.
93. Qiao, F., Moss, A. and Kupfer, G.M. (2001) Fanconi anemia proteins localize to chromatin and the nuclear matrix in a DNA damage and cell cycle-regulated manner. J. Biol. Chem., 276, 23391-23396.
94. Rathbun, R.K., Faulkner, G.R., Ostroski, M.H. et al. (1997) Inactivation of the Fanconi anaemia group C gene augments interferon γ-induced apoptotic responses in hematopoietic cells. Blood, 90, 974-985.
95. Rathbun, R.K., Christianson, T.A., Faulkner, G.R., Jones, G., Keeble, W., O'Dwyer, M. and Bagby, G.C. (2000) Interferon-gamma-induced apoptotic responses of Fanconi anaemia group C hematopoietic progenitor cells involve caspase 8-dependent activation of caspase 3 family members. Blood, 96, 4204-4211.
96. Ren, J. and Youssoufian, H. (2001) Functional analysis of the putative peroxidase domain of FANCA, the Fanconi anemia complementation group A protein. Mol. Genet. Metab., 72, 54-60.
97. Reuter, T., Herterich, H., Hoehn, H. and Gross, H.J. (2000) On our way to the function of the FA-proteins: yeast two hybrid FA-interactors are involved in chromatin modification. 12th Annual International Fanconi Anemia Symposium, Abstracts Book, p. 27.
98. Rey, J.P., Scott, R. and Muller, H. (1993) Induction and removal of interstrand cross-links in the ribosomal RNA genes of lymphoblastoid cell lines from patients with Fanconi anaemia. Mutat. Res., 289, 171.
99. Ridet, A., Guillouf, C., Duchaud, E., Cundari, E., Fiore, M., Moustacchi, E. and Rosselli, F. (1997) Deregulated apoptosis is a hallmark of the Fanconi anaemia syndrome. Cancer Res., 57, 1722-1730.
100. Río, P., Segovia, J.C., Hanenberg, H. et al.. (2002) In vitro phenotypic correction of hematopoietic progenitors from Fanconi anemia group A knockout mice. Blood, 100, 2032-2039.
101. Rosselli, F., Sanceau, J., Gluckman, E., Wietzerbin, J. and Moustacchi, E. (1994) Abnormal lymphokine production: a novel feature of the genetic disease Fanconi anaemia. II. In vitro and in vivo spontaneous overproduction of tumour necrosis factor α. Blood, 83, 1216-1225
102. Rosselli, F., Ridet, A., Soussi, T., Duchaud, E., Alapetite, C. and Moustacchi, E. (1995) P53-dependent pathway of radio-induced apoptosis is altered in Fanconi anaemia. Oncogene, 10, 9-17.
103. Ruppitsch, W., Meisslitzer, C., Hirsch-Kauffmann, M. and Schweiger, M. (1998) Overexpression of thioredoxin in Fanconi anemia fibroblasts prevents the cytotoxic and DNA damaging effect of mitomycin C and diepoxybutane. FEBS Lett., 422, 99-102.
104. Saito, H., Hammond, A.T. and Moses, R.E. (1993) Hypersensitivity to oxygen is a uniform and secondary defect in Fanconi anemia cells. Mutat. Res., 294, 255-262.
105. Saito, H., Hammond, A.T. and Moses, R.E. (1995) The effect of low oxygen tension on the in vitro replicative life span of human diploid fibroblast cells and their transformed derivatives. Exp. Cell Res., 217, 272-279.
106. Sala-Trepat, M., Rouillard, D., Escarceller, M., Laquerbe, A., Moustacchi, E. and Papadopoulo, D. (2000) Arrest of S-phase progression is impaired in Fanconi anemia cells. Exp. Cell. Res., 260, 208-215.
107. Schindler, C. and Darnell, J.E. (1995) Transcriptional responses to polypeptide ligands: the JAK-STAT pathway. Annu. Rev. Biochem., 64, 621-651.
108. Schindler, D. and Hoehn, H. (1988) Fanconi anaemia mutation causes cellular susceptibility to ambient oxygen. Am. J. Hum. Genet., 43, 429-435.
109. Scott, D., Spreadborough, A.R. and Roberts, S.A. (1994) Radiation-induced G2 delay and spontaneous chromosome aberrations in ataxia-telangiectasia homozygotes and heterozygotes. Int. J. Radiat. Biol., 66, S157-S163.
110. Scully, R. (2001) Interactions between BRCA proteins and DNA structure. Exp. Cell Res., 264, 67-73.
111. Seyschab, H., Sun, Y., Friedl, R., Schindler, D. and Hoehn, H. (1993) G2 phase cell cycle disturbance as a manifestation of genetic cell damage. Hum. Genet., 92, 61-68.
112. Seyschab, H., Bretzel, G., Friedl, R., Schindler, D., Sun, Y. and Hoehn, H. (1994) Modulation of the spontaneus G2 phase blockage in Fanconi anaemia cells by caffeine: differences from cells arrested by X-irradiation. Mutat. Res., 308, 149-157.
113. Siddique, H., Zou, J.P., Rao, V.N. and Reddy, E.S. (1998) The BRCA2 is a histone acetyltransferase. Oncogene, 16, 2283-2285.
114. Smith, J., Andrau, J.C., Kallenbach, S., Laquerbe, A., Doyen, N. and Papadopoulo, D. (1998) Abnormal rearrangements associated with V(D)J recombination in Fanconi anemia. J. Mol. Biol., 281, 815-825.
115. Strathdee, C.A. and Buchwald, M. (1992) Molecular and cellular biology of Fanconi anaemia. Am. J. Pediat. Hematol. Oncol., 14, 177-185.
116. Strathdee, C.A., Gavish, H., Shannon, W.R. and Buchwald, M. (1992a) Cloning of cDNAs for Fanconi's anaemia by functional complementation. Nature, 356, 763-767.
117. Strathdee, C.A, Duncan, A.M.V. and Buchwald, M. (1992b) Evidence for at least four Fanconi anaemia genes including FACC on chromosome 9. Nature Genet., 1, 196.
118. Surrallés, J., Hande, P.H., Marcos, R. and Lansdorp, P. (1999) Accelerated telomere shortening in the human inactive X chromosome. Am. J. Hum. Genet., 65, 1616-1622.
119. Surrallés, J., Ramírez, M.J., Marcos, R., Natarajan, A.T. and Mullenders, L.H.F. (2002) Clusters of transcription coupled repair in the human genome. Proc. Natl Acad. Sci. USA, 99, 10571-10574.
120. Takeuchi, T. and Morimoto, K. (1993) Increased formation of 8-hydroxydeoxyguanosine, an oxidative DNA damage, in lymphoblasts from Fanconi's anemia patients due to possible catalase deficiency. Carcinogenesis, 14, 1115-1120.
121. Taniguchi, T., Garcia-Higuera, I., Xu, B., Andreassen, P.R., Gregory, R.C., Kim, S.T., Lane, W.S., Kastan, M.B. and D'Andrea, A.D. (2002) Convergence of the Fanconi anemia and ataxia telangiectasia signaling pathways. Cell, 109, 459-472.
122. Thyagarajan, B. and Campbell, C. (1997) Elevated homologous recombination activity in Fanconi anemia fibroblasts. J. Biol. Chem., 272, 23328-23333.
123. Timmers, C., Taniguchi, T., Hejna, J. et al. (2001) Positional cloning of a novel Fanconi anemia gene, FANCD2. Mol. Cell, 7, 241-248.
124. Tipping, A.J., Pearson, T., Morgan, N.V. et al. (2001) Molecular and genealogical evidence for a founder effect in Fanconi anemia families of the Afrikaner population of South Africa. Proc. Natl Acad. Sci. USA, 98, 5734-5739.
125. Van Steensel, B., Smogorsewska, A. and de Lange, T. (1998) TRF2 protects human telomeres from end-to-end fusions. Cell, 92, 401-413.
126. Vlachodimitropoulos, D., Norppa, H., Autio, K., Catalan, J., Hirvonen, A., Tasa, G., Uuskula, M., Demopoulos, N.A. and Sorsa, M. (1997) GSTT1-dependent induction of centromere-negative and -positive micronuclei by 1,2:3,4-diepoxybutane in cultured human lymphocytes. Mutagenesis, 12, 397-403
127. Von Zglinicki, T., Pilger, R. and Sitte, N. (2000) Accumulation of single-strand breaks is the major cause of telomere shortening in human fibroblasts. Free Radic. Biol. Med., 28, 64-74.
128. Waisfisz, Q., Morgan, N.V., Savino, M. et al. (1999) Spontaneous funtional correction of homozygous Fanconi anemia alleles reveals novel mechanistic basis for reverse mosaicism. Nature Genet., 22, 379-383.
129. Walsh, C., Neinhuis, A., Samulski, R., Brown, M., Miller, J., Young, N. and Liu, J. (1994) Phenotypic correction of Fanconi anaemia in human hematopoietic cells with a recombinant adeno-associated virus vector. J. Clin. Invest., 94, 1440.
130. Wang, J., Otsuki, T., Youssoufian, H., Foe, J.L., Kim, S., Devetten, M., Yu, J., Li, Y., Dunn, D. and Liu, J.M. (1998) Overexpression of the fanconi anaemia group C gene (FAC) protects hematopoietic progenitors from death induced by Fas-mediated apoptosis. Cancer Res., 58, 3538-3541.
131. Whitney, M.A., Saito, H., Jakobs, P.M., Gibson, R.A., Moses, R.E. and Grompe, M. (1993) A common mutation in the FACC gene causes Fanconi anaemia in Ashkenazi Jews. Nature Genet., 4, 202-205.
132. Whitney, M.A., Royle, G., Low, M.J. et al. (1996) Germ cell defects and hematopoietic hypersensitivity to gamma-interferon in mice with targeted disruption of the Fanconi anaemia C gene. Blood, 88, 49-58.
133. Will, O., Schindler, D., Boiteux, S. and Epe, B. (1998) Fanconi's anaemia cells have normal steady-state levels and repair of oxidative DNA base modifications sensitive to Fpg protein. Mutat. Res., 409, 65-72.
134. Wong, J.C. and Buchwald, M. (2002) Disease model: Fanconi anemia. Trends Mol. Med., 8, 139-142.
135. Wood, R.D. (2001) Human DNA repair genes. Science, 291, 1284-1289.
136. Xu, B., Kim, S.T., Lim, D.S. and Kastan, M.B. (2002) Two molecularly distinct G(2)/M checkpoints are induced by ionizing irradiation. Mol. Cell. Biol., 22, 1049-1059.
137. Yamashita, T., Barber, D.L., Zhu,Y., Wu, N. and D'Andrea, A.D. (1994) The Fanconi anaemia polypeptide FACC is localised to the cytoplasm. Proc. Natl Acad. Sci. USA, 91, 6712-6716.
138. Youssoufian, H. (1994) Localization of Fanconi anaemia C protein to the cytoplasm of mammalian cells. Proc. Natl Acad. Sci. USA, 91, 7975-7979.
139. Zhen, W., Evans, M.K., Haggerty, C.M. and Bohr, V.A. (1993) Deficient gene specific repair of cisplatin-induced lesions in xeroderma pigmentosum and Fanconi's anaemia cell lines. Carcinogenesis, 14, 919.
140. Zhu, X.D., Kuster, B., Mann, M., Petrini, J.H. and de Lange, T. (2000) Cell-cycle-regulated association of RAD50/MRE11/NBS1 with TRF2 and human telomeres. Nature Genet., 25, 347-352.
141. Zunino, A., Degan, P., Vigo, T. and Abbondandolo, A. (2001) Hydrogen peroxide: effects on DNA, chromosomes, cell cycle and apoptosis induction in Fanconi's anemia cell lines. Mutagenesis, 16, 283-288.